Design and Development of Selective Muscarinic Agonists for the Treatment of Alzheimer's Disease: Characterization of Tetrahydropyrimidine Derivatives and Development of New Approaches to Improved Affinity and Selectivity for M1 Receptors
Article (Faculty180)